US HB6279 | 2021-2022 | 117th Congress

Status

Spectrum: Moderate Partisan Bill (Democrat 5-1)
Status: Introduced on December 14 2021 - 25% progression, died in committee
Action: 2022-11-01 - Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Pending: House Subcommittee on Crime, Terrorism, and Homeland Security Committee
Text: Latest bill text (Introduced) [PDF]

Summary

To authorize a study on certain exemptions for treatment of opioid use disorder through opioid treatment programs during the COVID-19 public health emergency, and for other purposes.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Opioid Treatment Access Act of 2022

Sponsors


History

DateChamberAction
2022-11-01HouseReferred to the Subcommittee on Crime, Terrorism, and Homeland Security.
2021-12-15HouseReferred to the Subcommittee on Health.
2021-12-14HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2021-12-14HouseIntroduced in House

Same As/Similar To

SB3629 (Related) 2022-02-10 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Subjects


US Congress State Sources


Bill Comments

feedback